3 Flashcards

1
Q

DEFICIENCY OF GRANULES

  1. structural defect in beta granules w/ corresponding abnormal aggregation responses & thrombocytopenia
    - characterized by _______ & _____ (most pronounced skeletal abnormality)
  2. autosomal dominant disorder characterized by abnormal proteolysis & deficiency of alpha granules
    - delayed for _____ of _____
    - excessive amounts of _____ which is a serine protease that helps in conversion of plasminogen to plasmin
A
  1. Thrombocytopenia w/ Absent Radii Syndrome (TAR)
    - severe neonatal thrombocytopenia & extreme hypoplasia of radial bones
  2. Quebec Platelet Disorder
    - 12-24hrs mucocutaneous bleeding
    - urokinase-type plasminogen activator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DISORDERS OF PLATELET PROCOAGULANT ACTIVITIES

During rest:
1. Located in inner leaflet
2. Located in outer leaflet

During platelet activation:
1. This process happens

Disorders:
1. surface expression of phospatidylserine is decreased (phospatidylserine doesn’t come out)
2. platelets are always in an activated state w/o prior activation
- there’s high ___ levels even there’s no vascular injury
- hence ____ & _____ are consumed entirely
3. Both disorders are due to

A

During rest:
1. phosphatidylserine (PS) & phosphatidamine (PE)
2. phosphatidylcholine

During platelet activation:
1. Platelet Membrane Phospholipid Scrambling

Disorders:
1. Scott Syndrome
2. Stormorken Syndrome
- calcium levels
- spontaneous aggregation and coagulation factors
3. genetic mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACQUIRED DEFECTS OF PLATELET FUNCTION

  1. Drug related
    - NSAIDS meaning
    - COX2 inhibitors (2)
    - COX2 inhibitors inhibits the activity of ____ which is precursor of thromboxane a2 which helps vasoconstriction & platelet aggregation
    - other antiplatelet agents (2) that helps prevents clumping of platelet during
    platelet aggregation
    - coats the surface of platelets where there are glycoproteins, there’s no binding w/ fibrinogen which will inhibit platelet aggregation
  2. 2 Disorders in paraproteinemias
    - increased protein in blood
    - increased IgM
    - excessive plasma protein lead to
  3. Renal disease
    - this leads to decreased thromboxane synthesis, decreased adhesion, decreased
    platelet release, and decreased aggregation
    - exhibited during ____ renal disease only
A
  1. Drug related
    - non- steroidal anti inflammatory drugs
    - naproxen & ibuprofen
    - cyclooxygenase
    - ticlopidine & clopidogrel)
    - dextran

2.
- multiple myeloma
- waldenstrom macroglobulinemia
- hyperviscosity syndrome

  1. Renal disease
    - uremia
    - end stagerenal disease only
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Significant Platelet Levels

  1. abnormally low
  2. bleeding possible
  3. spontaneous bleeding
  4. evere spontaneous bleeding
A
  1. <100,000/uL
  2. 30,000-50,000/uL
  3. <30,000/uL
  4. <5,000/uL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

THROMBOCYTOPENIA: Decreased Production

Megakaryocyte Hypoproliferation in:
1. genetic disorder that affects the blood cells esp. platelets & wbcs
- ____ can only infect neutrophils
- may-hegglin inefects (3)
2. in neonatal thrombocytopenia:
- TORCH stands for
- in-utero exposure to certain drugs

A
  1. May-Hegglin
    - dohle bodies
    - BEN
    • toxoplasmosis, other agents, rubella, cytomegalovirus, herpes
    • chlorothiazide diuretics & oral hypoglycemic tolbutamide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

THROMBOCYTOPENIA: Decreased Production.2

Two other causes in decreased production
1. seen in megaloblastic anemias
2. ________ by abnormal cells

A
  1. Ineffective thrombopoiesis
  2. Marrow replacement (infiltration) by abnormal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

THROMBOCYTOPENIA: Blood Transfusion

    • recipient’s plasma is found to contain
      2.
A
  1. Platelet-containing blood products
    - alloantibodies
  2. Massive transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

THROMBOCYTOPENIA: Increased Destruction or Consumption

Non Immune
1. deficiency of disintegrin & metalloproteinase w/ thrombospondin type 1 motif member
- what is this motif member
- when there’s deficiency of this enzyme/motif me,her, excess platelet adhesion causes ______
2. activation of both coagulation & fibrinolysis due to liberation of thromboplastin substances by damaged or abnormal cells/ epithelial cells
- three bacteria’s that produces toxin
- E.coli release toxin called
3. example of infection that causes decreased platelets

A

Non Immune
1. Thrombotic Thrombocytopenic Purpura
- ADAMTS-13
- thrombus
2. Disseminated Intravascular Coagulation (DIC)
- E.coli O157:H7, Shiga, or Vero toxin-producing bacteria
- Shiga-like toxin 1 or 2
3. dengue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

THROMBOCYTOPENIA: Increased Destruction or Consumption

Immune
1. common in females
- presence of ____
- acute ITP common in
- chronic ITP common in
2. Drug Induced, which is called _______
- patient develops IgG
antibody specific for _____
- they gives _____

A

Immune
1. Immune Thrombocytopenic Purpura
- anti-platelet antibodies of IgG
- children
- adults
2. Heparin-Induced Thrombocytopenia
- heparin-platelet factor 4 complexes
- unfunctionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

THROMBOCYTOPENIA:
_____: removal of platelets in circulation
1. seen in ____ & ____

THROMBOCYTOSIS/ THROMBOCYTHEMIA:
1. Primary thrombocytosis are seen in
2. Secondary are seen in ____ (removal of spleen) & _____

A

THROMBOCYTOPENIA:

Splenic sequestration
1. hypersplenism & splenomegaly

THROMBOCYTOSIS/ THROMBOCYTHEMIA:
1. myeloproliferative disorders
2. splenic mobilization; hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly